Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Gemfrac Injection

Prescription Icon
Prescription Required

Marketer

Alkem Laboratories Ltd

Salt Composition

Teriparatide (600mcg)

Overview Gemfrac Injection

Parathyroid hormone therapy, specifically Gemfrac Injection, is a synthetic treatment for severe osteoporosis in men and postmenopausal women at heightened fracture risk. This medication stimulates bone growth, thereby increasing bone density and reducing spinal fracture probability. Gemfrac Injection is administered subcutaneously or by a medical professional. Consistent daily dosing is crucial for optimal efficacy. Treatment typically lasts up to two years, although the physician's recommendations should be followed diligently, regardless of symptom improvement. Refrigerate the medication between 2°C and 8°C. Common adverse effects encompass joint pain, injection site inflammation (pain, swelling, redness), and leg spasms; report persistent or bothersome side effects to your doctor. Prior to commencing therapy, disclose any kidney issues, including kidney stones, as Gemfrac Injection may elevate blood or urine calcium levels. Pregnant or lactating individuals should seek medical counsel before using this medication. Your doctor might order bone density scans to track treatment progress.

Uses of Gemfrac Injection

Brittle bone disease

Major Benefits of Gemfrac Injection:

Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Gemfrac Injection:

  • Joint pain
  • Injection site reactions (pain, swelling, redness)
  • Nausea
  • Leg cramps

How to use Gemfrac Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Gemfrac Injection works:

Gemfrac Injection is a manufactured analog of the naturally occurring parathyroid hormone (PTH). Its mechanism of action involves stimulating osteoblast proliferation and activity, leading to enhanced bone strength and a reduced fracture risk.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when combining Gemfrac Injection with alcohol. Physician consultation is recommended.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Gemfrac Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on Gemfrac Injection use while breastfeeding is absent. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Administering Gemfrac Injection might reduce attentiveness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if these effects manifest.

KidneyKidneyCAUTION

Individuals with kidney impairment should receive Gemfrac Injection cautiously, potentially requiring dosage modification. Physician consultation is advised. Gemfrac Injection is contraindicated for patients exhibiting severe kidney dysfunction.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding Gemfrac Injection's use in individuals with hepatic impairment. Physician consultation is recommended.

What if you forget to take Gemfrac Injection :

Should you forget a Gemfrac Injection dose, administer it at your earliest convenience. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Gemfrac Injection

LabelValue
Pharmaceutical Category Synthetic Parathyroid Hormone Preparations
Addictive None.
Type of Medication Endocrine regulators

FAQs on Gemfrac Injection

Gemfrac Injection does not contain steroids. It's prescribed to manage osteoporosis, a condition sometimes resulting from prolonged steroid use. This medication is typically administered to postmenopausal women and men at heightened fracture risk.
Gemfrac Injection treatment should not exceed two years. Prior Gemfrac Injection use must be disclosed to your physician, as lifelong treatment is limited to a single, 24-month course.
Store Gemfrac Injection pens refrigerated between 2°C and 8°C. Freezing damages the medication, reducing its effectiveness; avoid proximity to the freezer compartment. Discard the pen after 28 days from the first injection, even if not completely used.
A physician will determine the necessity of this medication for each patient. Gemfrac Injection is contraindicated in several situations, including kidney dysfunction, Paget's disease, bone malignancies, and unexplained hypercalcemia. It should also be avoided in children, adolescents, pregnant women, and breastfeeding mothers. Therefore, disclose all pre-existing medical conditions and current medications to your doctor before commencing treatment. This allows for the creation of a personalized treatment plan.
Gemfrac Injection
3,283
MRP 4,000
17% off